Cover Image

Malignant Brenner tumor associated with a germline BRCA2 mutation

Saved in:

Bibliographic Details
Main Authors:	Michael D. Toboni (Author), Haller J. Smith (Author), Sarah E. Dilley (Author), Lea Novak (Author), Charles A. Leath (Author)
Format:	Book
Published:	Elsevier, 2017-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
by: Yinmei Zhang, et al.
Published: (2024)

Malignant Brenner tumor: Two case reports
by: Luke King, et al.
Published: (2018)

The occurrence of germline <it>BRCA1 </it>and <it>BRCA2 </it>sequence alterations in Slovenian population
by: Hočevar Marko, et al.
Published: (2011)

Malignant Brenner tumor of the ovary: Review and case report
by: Susan M. Lang, et al.
Published: (2017)

Bilateral malignant ovarian tumor: a rare combination of mixed epithelial tumor - serous adenocarcinoma with Brenner's and pure Brenner's tumor
by: Sonia H, et al.
Published: (2023)

Patterns and duration of primary and recurrent treatment in ovarian cancer patients with germline BRCA mutations
by: Soledad Jorge, et al.
Published: (2019)

Contribution of germline <it>BRCA1 </it>and <it>BRCA2 </it>sequence alterations to breast cancer in Northern India
by: Sharma Veena K, et al.
Published: (2006)

Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation: a case report
by: Yi Ma, et al.
Published: (2018)

Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations
by: Avantika Lal, et al.
Published: (2019)

Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer
by: Na Li, et al.
Published: (2021)

Malignant Brenner tumor of the ovary: Case series and review of treatment strategies
by: Yingao Zhang, et al.
Published: (2019)

Ovarian Mixed Malignant Brenner-Mucinous Tumor with Signet Ring Cells
by: Baharak Khadang, et al.
Published: (2020)

BRCA1 and BRCA2 Mutations Diagnostic and Therapeutic Implications
Published: (2023)

Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series
by: Koji Matsuo, et al.
Published: (2015)

Malignant Brenner tumor of the ovary: Pathologic evaluation, molecular insights and clinical management
by: Tiannan Wang, et al.
Published: (2024)

Laparoscopic treatment of Castleman's disease in a patient with a history of malignant Brenner tumor
by: Won Moo Lee, et al.
Published: (2016)

Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations
by: Brooke E. Sanders, et al.
Published: (2022)

Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants - an Asian study of 572 familiesResearch in context
by: Weang-Kee Ho, et al.
Published: (2024)

40 Comparison of contemporary management and outcomes of patients with transitional cell carcinomas and malignant Brenner tumors of the ovary
by: Katherine Coakley, et al.
Published: (2023)

Coexisting brenner tumor and endometrial carcinoma
by: Mitakshara Sharma, et al.
Published: (2017)

TUMOR DE BRENNER BILATERAL BENIGNO
by: Ana Martínez Aspas, et al.
Published: (2009)

Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report
by: Ying Liu, et al.
Published: (2022)

Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation?
by: Sabah Alaklabi, et al.
Published: (2023)

Tumor de Brenner maligno: caso clínico
by: Elena Sosa C, et al.
Published: (2012)

Primary ovarian lymphoma and benign Brenner tumor
by: Antonia Pavlovic, et al.
Published: (2016)

BRCA1, BRCA2 mutations - future of predictive oncology: a review of literature
by: V. N. Dmitriev, et al.
Published: (2014)

Cost-effectiveness of fuzuloparib compared to routine surveillance, niraparib and olaparib for maintenance treatment of patients with germline BRCA1/2 mutation and platinum-sensitive recurrent ovarian carcinoma in China
by: Jing Nie, et al.
Published: (2023)

Role of BRCA 1 и BRCA 2 gene mutations in the occurrence of male breast cancer
by: A. V. Bykova, et al.
Published: (2014)

Prophylactic adnexectomy in BRCA1 and BRCA2 gene mutation carriers (а review of literature)
by: T. A. Shendrikova, et al.
Published: (2014)

BRCA1 and BRCA2 Gene Mutations Screening In Sporadic Breast Cancer Patients In Kazakhstan.
by: Ainur R. Akilzhanova, et al.
Published: (2013)

Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers
by: Alan D McCrorie, et al.
Published: (2020)

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
by: Tarinee Manchana, et al.
Published: (2020)

Editorial: BRCA1 and BRCA2 genes mutations screening in sporadic breast cancer patients in Kazakhstan
by: Rachel C. Jankowitz, et al.
Published: (2013)

Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report
by: Kayo Inoue, et al.
Published: (2020)

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
by: Roshni D. Kalachand, et al.
Published: (2020)

Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers
by: Renata Faermann, et al.
Published: (2022)

A borderline ovarian Brenner tumor mimicks uterine fibroids
by: Chun-Chieh Chia, et al.
Published: (2011)

Coexistence of Benign Brenner Tumor with Mucinous Cystadenoma in an Ovarian Mass
by: Farzaneh Nazari, et al.
Published: (2020)

Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation
by: Tahireh Markert, et al.
Published: (2022)

High rate of mutations in the BRCA1, BRCA2, CHEK2, NBN, and BLM genes in Russian ovarian cancer patients
by: Ye. I. Bateneva, et al.
Published: (2015)